Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Pelthos Therapeutics (PTHS) Leases (2025)

Pelthos Therapeutics has reported Leases over the past 1 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Leases at $3.2 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $3.2 million (changed N/A YoY), and the annual figure for FY2025 was $3.2 million, changed.
  • Leases for Q4 2025 was $3.2 million at Pelthos Therapeutics, down from $5.9 million in the prior quarter.
  • Over the last five years, Leases for PTHS hit a ceiling of $5.9 million in Q3 2025 and a floor of $3.2 million in Q4 2025.